Tolerability and efficacy study of P2X7 inhibition in experimental 
Charcot-Marie-Tooth type 1A (CMT1A) neuropathy

Sociali, Giovanna; Visigalli, Davide; Prukop, Thomas; Cervellini, Ilaria; Mannino, Elena; Venturi, Consuelo; Bruzzone, Santina; Sereda, Michael W.; Schenone, Angelo

doi:10.1016/j.nbd.2016.07.017

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2321191_3

DetailsSummary

Released

Journal Article

Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy

MPS-Authors

/persons/resource/persons182356

Prukop, Thomas
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182113

Cervellini, Ilaria
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182406

Sereda, Michael W.
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Sociali, G., Visigalli, D., Prukop, T., Cervellini, I., Mannino, E., Venturi, C., et al. (2016). Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease, 95(11), 145-157. doi:10.1016/j.nbd.2016.07.017.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-0F3F-E

Abstract

There is no abstract available